Laboratorios Sanfer completed the acquisition of Vitalis from ACON Investments.

Laboratorios Sanfer, a pharmaceutical company, completed the acquisition of Vitalis, a manufacturer and wholesaler of injectable products used in hospitals, medical institutions and pharmacies, from ACON Investments, a private equity firm. Financial terms were not disclosed. "This has been a very successful investment for us and exemplifies ACON's disciplined, value-driven strategy and our ability to deliver strong performance despite dynamic market conditions. Our collaboration with Vitalis showcases ACON's ability to grow businesses across Latin America while working alongside management teams to drive sustainable growth, foster innovation and create lasting social and environmental impact," Alberto Hernández, ACON Investments Partner.